COMET Trial Finds Active Monitoring Is a Viable Option for Some Patients With Low-risk DCIS
Recurrence risk was similar between active monitoring and usual care groups SAN ANTONIO – Among patients with hormone receptor...
Recurrence risk was similar between active monitoring and usual care groups SAN ANTONIO – Among patients with hormone receptor...
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional,...
SAN ANTONIO – Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have...
Imlunestrant was effective in combination with abemaciclib, and as monotherapy in ESR1-mutated breast cancer SAN ANTONIO – Imlunestrant, an investigational...
SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40...
Symptoms were associated with lower mental quality of life for both Black and white patients LOS ANGELES – Among...
Among patients who received immunotherapy, outcomes were similar between Black and white patients LOS ANGELES – In recent years,...
LOS ANGELES – The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white...
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
SAN DIEGO – Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated...